Overview
XOMA’s extensive antibody expertise includes antibody discovery, optimization, preclinical and clinical development, regulatory, and cGMP manufacturing.
We combine access to multiple antibody discovery and development technologies with intellectual property, technical expertise and know-how, and integrated infrastructure to gain a unique advantage in the rapid and efficient development of therapeutic human antibodies.
The breadth of our capabilities provides a distinctive and comprehensive drug development process.
TechnologyLearn about XOMA's antibody phage libraries and Bacterial Cell Expression (BCE) technology.
CapabilitiesFind out more about XOMA's fully integrated product development infrastructure.




